The National Organization for Rare Disorders (NORD)

Database Subscriptions

Many libraries, schools, universities, and hospitals subscribe to NORD’s Rare Disease Database for unlimited access to reports on more than 1,200 diseases.

Index of Rare Diseases

This is the list of diseases currently covered in the Rare Disease Database.

Rare Disease Database

Search this database for reports on more than 1,200 diseases.

View sample report

Index of Organizations

This is the list of organizations in NORD’s Organizational Database.

Organizational Database

Read about more than 2,000 patient organizations and other sources of help.

NORD's
Washington Office

NORD's Washington OfficeRead about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.

 



Aceruloplasminemia

To purchase full-text report ($7.50):
View Cart/Checkout

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

The information in NORD's Rare Disease Database is for educational purposes only. It should never be used for diagnostic or treatment purposes. If you have questions regarding a medical condition, always seek the advice of your physician or other qualified health professional. NORD's reports provide a brief overview of rare diseases. For more specific information, we encourage you to contact your personal physician or the agencies listed as "Resources" on this report.

Copyright 2010

NORD is very grateful to Alisdair McNeill, MD, Specialist Registrar in Medical Genetics, Regional Clinical Genetics Unit, Birmingham Womens Hospital, UK, for assistance in the preparation of this report.

Synonyms of Aceruloplasminemia
  • familial apoceruloplasmin deficiency
  • hereditary ceruloplasmin deficiency

Disorder Subdivisions



General Discussion
Aceruloplasminemia is a rare genetic disorder characterized by the abnormal accumulation of iron in the brain and various internal organs. Affected individuals develop neurological symptoms including cognitive impairment and movement disorders. Degeneration of the retina and diabetes may also occur. Symptoms usually become apparent during adulthood between 20 and 60 years of age. Aceruloplasminemia is caused by mutations of the ceruloplasmin (CP) gene. This mutation is inherited as an autosomal recessive trait.

Aceruloplasminemia is classified as a Neurodegenerative disorder with Brain Iron Accumulation (NBIA). NBIA are a group of rare inherited disorders characterized by iron accumulation in the brain. Aceruloplasminemia is also classified as an iron overload disorder.

Organizations related to Aceruloplasminemia
  • Iron Disorders Institute
    PO Box 675
    Taylors SC 29687
    Phone #: 864-292-1175
    800 #: 888-565-4766
    e-mail: info@irondisorders.org
    Home page: http://www.irondisorders.org
  • Iron Overload Diseases Association, Inc.
    433 Westwind Drive
    PO Box 15857
    West Palm Beach Fl 33416-5857
    Phone #: 561-586-8246
    800 #: 866-768-8629
    e-mail: iod@ironoverload.org
    Home page: http://ironoverload.org
  • NBIA Disorders Association
    2082 Monaco Court
    El Cajon CA 92019-4235
    Phone #: 619-588-2315
    800 #: --
    e-mail: info@nbiadisorders.org
    Home page: http://www.NBIAdisorders.org

ABOUT NORD .|. CONTACT NORD .|. MEMBERSHIP .|. PRIVACY POLICY .|. DISCLAIMER .|. HOME
©2009 NORD - National Organization for Rare Disorders, Inc. All rights reserved.

Last modified Tuesday, September 07, 2010